Patient
SITE011-0218
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE011 (ITA) (Dr. Jansen)
consented 2026-05-18
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 4
Grade 3 Pruritus — outcome: RECOVERED/RESOLVED; onset 2023-02-28 (study day 93); relationship: not assessed
Grade 1 Alanine aminotransferase increased — outcome: RECOVERED/RESOLVED; onset 2023-02-07 (study day 72); relationship: not assessed
Grade 1 Hepatitis — outcome: RECOVERED/RESOLVED; onset 2023-01-11 (study day 45); relationship: not assessed
Grade 2 Fatigue — outcome: RECOVERED/RESOLVED; onset 2022-12-04 (study day 7); relationship: NOT RELATED
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.